Luoxin Pharma updates articles of association

Luoxin Pharmaceuticals Group Stock (SZSE:002793) has updated its Articles of Association, effective February 2025, to reflect regulatory changes and internal governance practices. Key updates include revisions to shareholder rights and obligations, board composition and duties (including independent directors), financial accounting and auditing procedures, and profit distribution policies. The articles also address procedures for mergers, acquisitions, dissolution, and liquidation. Updates to executive compensation, labor, and union policies have been made. These changes were approved by the Board, then will be approved by the shareholders. The updated articles were written in Chinese, which is the final agreement if different English articles exist.